Trial intelligence / Profile preview

Intraoperative photodynamic diagnosis using 5-aminolevulinic acid in breast cancer surgery

jRCTs041250095Suspended

Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of 5-aminolevulinic acid in breast cancer. Primary endpoint: Usefulness of photodynamic diagnosis versus gross diagnosis. Started Sep 2025; status: suspended.

02

Drugs

5-aminolevulinic acid
03

Conditions

breast cancer

Beyond the preview

Go deeper on jRCTs041250095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041250095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call